Collectively, the results of our present study uncovered a novel PRMT5/FBW7/cMyc axis in pancreatic cancer, and targeting this axis might be a strategy for the treatment of pancreatic cancer. The gene discussed is PRMT5; the disease is familial pancreatic carcinoma.